Canada India Health Care Summit May 19

Canada India Health Care Summit
May 19-20 2015
BlueOcean NutraSciences (“BlueOcean”) is listed on the
TSX Venture Exchange (TSXV:BOC)
This presentation contains certain forward-looking statements. Forward-looking statements are
statements that are not historical facts, and include but are not limited to, estimates and their
underlying assumptions, statements regarding plans, objectives and expectations with respect to the
effectiveness of BlueOcean’s business model, future operations, products and services; the impact
of regulatory initiatives on BlueOcean’s operations, the size of and opportunities related to the
markets for their products; general industry and macroeconomic growth rates, expectations related
to possible joint and/or strategic ventures and statements regarding future performance.
The forward-looking statements contained in this presentation are made as of the date hereof.
Unless required by law, BlueOcean’s does not undertake any obligation to update publically or to
revise any of the included forward-looking statements, whether as a result of new information,
future events or otherwise The Common Shares of the Corporation have not been and will not be
registered under the United States Securities Act of 1933, as amended and may not be offered or
sold in the United States absent registration or an applicable exemption from the registration
requirement. This presentation shall not constitute an offer to sell or the solicitation of an offer to
buy, nor shall there be any sale of any securities of the Corporation in any
jurisdiction in which such offer, solicitation or sale would be unlawful.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the
content of this presentation.
All figures are in United States Dollars (US$) unless otherwise stated.
BlueOcean’s Management Bios
Gavin Bogle, JD, MBA, MS – Chief Executive Officer
Mr. Bogle has been an intellectual property, regulatory, and licensing attorney for over 20
years in mostly the North American biotechnology, pharmaceutical and supplement
industries. He has extensive cross-border transactional experience including intellectual
property aspects of corporate transactions such as licensing, contracts and collaborations,
acquisitions, financings, divestitures and managing intellectual property holdings.
Benefits of Omega 3
In a special edition of Military Medicine: “Nutritional Armor: Omega-3 for the Warfighter”.
…
The Panel concluded that there was “sufficient evidence to support increasing omega-3
intake to receive
cardiovascular,
immunological,
and surgical benefits.”
…
... Evidence for reduction of depressive symptoms and suicide prevention was felt to be strong
…
Adverse side effects were deemed negligible.
“The Panel concluded that based on studies analyzing omega-3 and omega-6 FA balance, it
would be unethical to not attempt elevating the omega-3 status among U.S. military
personnel.”
See: “US Military Evalulating Benefits of Omega-3 Supplementation By Michael McBurney”
http://www.dsm.com/campaigns/talkingnutrition/en_US/talkingnutrition-dsmcom/2014/11/us_military_evalulate_omega3.html”
BlueOcean’s AstaShrimp Oils
AstaShrimp oils are dark red due to high
natural Astaxanthin content.
AstaShrimp oils are viscous liquids due to high
phospholipids content. These oils can be blended
with other fish oils to reduce viscosity if desired.
BlueOcean’s AlgaOmega Oil
BlueOcean has a proprietary patented CO2 gas infusion technology to make high yielding
non-GMO high omega-3 EPA/DHA algal oils for vegetarian and adult customers.
Commercial
Strategy
• Forming a JV or an out-license with a commercial algae
omega-3/nutraceutical company
• BlueOcean continues to explore building a wholly
owned algae plant for its own AlgaOmega oils
BlueOcean’s Nutra Tablets
BlueOcean converts shrimp, krill, algae and other fish oils into slow
release Omega-3 oil tablets
• First Omega-3 oil tablets on the market
• 500 mg tablet sizes that can vary in size,
shape and color
• Tablet oils can be shrimp, krill, omega-3
and astaxanthin algae, and fish oils
• Custom formulations of EPA, DHA,
Astaxanthin and Phospholipids
• Extended release and high bioavailability from pharmaceutical applied
technology
• No fishy smell, taste or burping
• NO SOFT GELS = NO BEEF PRODUCTS
Fish oil tablets with 500 mg of oil containing
36% EPA & 24% DHA
BlueOcean’s Strong Indian Partnership
INDFRAG LIMITED
•
In 1989 Indfrag was started to extract the essence of natural flowers to be
used as ingredients in fine perfumery in collaboration with Bertrand Freres
located in the south of France
•
In the early 1990s, Indfrag diversified and expanded into botanical extracts
used in Healthcare such as Garcinia
•
Indfrag has grown to be one of the largest extraction facilities in India with
a total of nine extraction facilities across Asian countries
•
Today Indfrag can load 400 metric tonnes of raw botanical every month.
•
GMP regulation certified by NSF.
BlueOcean’s Strong Indian Partnership
INDFRAG
BlueOcean’s Indian Omega-3 Market Opportunity
India’s Omega-3 Market
• $1.5B Dietary Supplements Market
• High growth market – 16% CAGR
• Only 5% of the Indian market is Omega-3’s
Challenges with Indian
Omega-3 use
• >30% of population is strict vegetarian
• >75% of India’s population is Hindu and
therefore DOES NOT EAT BEEF, but 60% still eat
chicken and seafood
• Omega-3 fish oil gel caps are BEEF GELATIN
• Gelcaps are 4 times more expensive vs tablets
BlueOcean’s Solutions For
Indian Omega-3 use
• For India’s 600M non-vegetarian but non beef
consumers: Omega-3 Fish and Shrimp Oil Tablets
• For the 300M vegetarians: Omega-3 Algae Tablets
Thank You
For more information please contact us:
Gavin.Bogle@blueoceannutra.ca
Tel: 416-970-3266
www.blueoceannutra.ca